As Exxon Mobil (XOM) Valuation Declined, Gyroscope Capital Management Group Trimmed Its Stake by $677,705; New England Professional Planning Group Has Cut Pfizer (PFE) Position as Stock Value Rose

Pfizer Inc. (NYSE:PFE) Logo

New England Professional Planning Group Inc decreased its stake in Pfizer Inc (PFE) by 3.43% based on its latest 2018Q3 regulatory filing with the SEC. New England Professional Planning Group Inc sold 7,698 shares as the company’s stock rose 5.56% while stock markets declined. The hedge fund held 216,897 shares of the health care company at the end of 2018Q3, valued at $9.55 million, down from 224,595 at the end of the previous reported quarter. New England Professional Planning Group Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $244.69B market cap company. The stock decreased 1.28% or $0.55 during the last trading session, reaching $42.33. About 8.29 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 25.07% since January 14, 2018 and is uptrending. It has outperformed by 25.07% the S&P500. Some Historical PFE News: 24/05/2018 – DOJ: Pfizer in Five-Year Corporate Integrity Agreement With Health & Human Services; 29/03/2018 – Pfizer’s rare disease drug succeeds in late-stage study; 30/05/2018 – Pfizer Closes Above 200-Day Moving Average: Technicals; 12/04/2018 – PFIZER CEO SAID BMY `NOT WORTH PAYING THE MONEY FOR’: CITI; 07/05/2018 – Pfizer at Deutsche Bank Health Care Conference Tomorrow; 08/03/2018 – Pfizer is the latest big drug company to give up on neuroscience research; 23/04/2018 – PFIZER RECEIVED A COMPLETE RESPONSE LETTER; 08/05/2018 – XTALPI REPORTS STRATEGIC RESEARCH PACT WITH PFIZER TO DEVELOP; 10/04/2018 – Pfizer: Recommendation Was Based on Failure to Demonstrate Clear Improvement in Primary Endpoint; 12/04/2018 – PFIZER INITIATES DUCHENNE MUSCULAR DYSTROPHY STUDY

Gyroscope Capital Management Group Llc decreased its stake in Exxon Mobil Corp (XOM) by 28.44% based on its latest 2018Q3 regulatory filing with the SEC. Gyroscope Capital Management Group Llc sold 7,973 shares as the company’s stock declined 6.33% with the market. The institutional investor held 20,059 shares of the integrated oil company at the end of 2018Q3, valued at $1.71M, down from 28,032 at the end of the previous reported quarter. Gyroscope Capital Management Group Llc who had been investing in Exxon Mobil Corp for a number of months, seems to be less bullish one the $303.18B market cap company. The stock decreased 0.15% or $0.11 during the last trading session, reaching $71.61. About 4.60M shares traded. Exxon Mobil Corporation (NYSE:XOM) has declined 7.28% since January 14, 2018 and is downtrending. It has underperformed by 7.28% the S&P500. Some Historical XOM News: 12/04/2018 – EXXONMOBIL XOM.N – PRODUCTION SAFELY RESTARTS AHEAD OF SCHEDULE AT PNG LNG PLANT NEAR PORT MORESBY; 12/04/2018 – Oil Search, Santos say PNG LNG project resumes production after quake; 10/04/2018 – Exxon, Qatar in Talks on U.S. Shale Deal; 30/04/2018 – Facebook, Google and Netflix pay a higher median salary than Exxon, Goldman Sachs or Verizon:; 05/03/2018 – CERAWEEK – OPEC DOES NOT PLAN ‘PRESSURE’ FOR COMPANIES OPERATING IN MEMBER COUNTRIES, U.S. SHALE, BUT WANTS DIALOGUE -NIGERIAN ENERGY MINISTER; 10/04/2018 – Qatar Petroleum Could Invest in Future U.S. Shale Wells With Exxon Unit XTO Energy; 09/05/2018 – Exxon Mobil Unit Sells Italy Refinery, Fuel Terminals to Algeria; 19/03/2018 – EXXONMOBIL BUYS LNG CARGO FOR QUAKE-HIT PAPUA NEW GUINEA FACILITY FOR EARLY APRIL – TRADERS; 21/05/2018 – Ghana Is Said to Favor Forecourt Operator as Exxon Mobil Partner; 07/03/2018 – FOCUS-Exxon CEO struggles to reverse Tillerson’s legacy of failed bets

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on January, 29 before the open. They expect $0.64 EPS, up 3.23% or $0.02 from last year’s $0.62 per share. PFE’s profit will be $3.70 billion for 16.54 P/E if the $0.64 EPS becomes a reality. After $0.78 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -17.95% negative EPS growth.

Since July 20, 2018, it had 0 insider purchases, and 2 sales for $1.92 million activity. 10,214 shares valued at $418,774 were sold by OLSON LAURIE J on Monday, August 13.

Among 23 analysts covering Pfizer (NYSE:PFE), 8 have Buy rating, 1 Sell and 14 Hold. Therefore 35% are positive. Pfizer had 89 analyst reports since July 29, 2015 according to SRatingsIntel. On Friday, October 2 the stock rating was upgraded by Morgan Stanley to “Overweight”. The stock of Pfizer Inc. (NYSE:PFE) earned “Market Perform” rating by Leerink Swann on Monday, May 2. The firm has “Outperform” rating by BMO Capital Markets given on Wednesday, May 2. Jefferies maintained Pfizer Inc. (NYSE:PFE) rating on Monday, February 26. Jefferies has “Hold” rating and $39.0 target. Morgan Stanley maintained Pfizer Inc. (NYSE:PFE) on Thursday, August 23 with “Overweight” rating. As per Tuesday, November 21, the company rating was maintained by BMO Capital Markets. The rating was initiated by Societe Generale on Wednesday, April 6 with “Hold”. Piper Jaffray maintained Pfizer Inc. (NYSE:PFE) rating on Saturday, September 5. Piper Jaffray has “Overweight” rating and $51 target. The firm has “Neutral” rating given on Friday, March 24 by Societe Generale. The stock has “Buy” rating by Argus Research on Wednesday, July 29.

Investors sentiment increased to 0.85 in 2018 Q3. Its up 0.07, from 0.78 in 2018Q2. It increased, as 41 investors sold PFE shares while 741 reduced holdings. 142 funds opened positions while 520 raised stakes. 3.96 billion shares or 0.44% less from 3.98 billion shares in 2018Q2 were reported. Wedgewood Investors Pa holds 12,523 shares. Hanson Mcclain owns 13,387 shares for 0.03% of their portfolio. Blume owns 6,274 shares or 0.14% of their US portfolio. Ashfield Capital Prtn Limited Company invested 0.46% of its portfolio in Pfizer Inc. (NYSE:PFE). Van Cleef Asset Managementinc invested 1.02% of its portfolio in Pfizer Inc. (NYSE:PFE). Gofen Glossberg Lc Il invested in 0.7% or 463,291 shares. Pure Financial Advsrs stated it has 0.29% in Pfizer Inc. (NYSE:PFE). Becker Cap Mgmt holds 2.21% of its portfolio in Pfizer Inc. (NYSE:PFE) for 1.58M shares. The Switzerland-based Banque Pictet And Cie has invested 0.15% in Pfizer Inc. (NYSE:PFE). Sns Ltd Limited Liability Company holds 1.16% or 109,977 shares in its portfolio. 148,162 are owned by Bridges. Price Mngmt has invested 0.53% in Pfizer Inc. (NYSE:PFE). Aureus Asset Ltd Liability Com accumulated 8,174 shares. Grandfield Dodd Ltd Liability Company owns 80,784 shares. Somerville Kurt F owns 38,622 shares.

Gyroscope Capital Management Group Llc, which manages about $127.73 million and $243.98 million US Long portfolio, upped its stake in Prudential Finl Inc (NYSE:PRU) by 6,263 shares to 73,628 shares, valued at $7.69M in 2018Q3, according to the filing. It also increased its holding in Lyondellbasell Industries N (NYSE:LYB) by 5,048 shares in the quarter, for a total of 66,178 shares, and has risen its stake in Firstenergy Corp (NYSE:FE).

Among 29 analysts covering Exxon Mobil (NYSE:XOM), 12 have Buy rating, 6 Sell and 11 Hold. Therefore 41% are positive. Exxon Mobil had 103 analyst reports since July 22, 2015 according to SRatingsIntel. Barclays Capital maintained the shares of XOM in report on Tuesday, October 10 with “Overweight” rating. The stock of Exxon Mobil Corporation (NYSE:XOM) earned “Hold” rating by BMO Capital Markets on Wednesday, January 10. The stock of Exxon Mobil Corporation (NYSE:XOM) has “Conviction Buy” rating given on Wednesday, July 22 by Goldman Sachs. Wells Fargo maintained Exxon Mobil Corporation (NYSE:XOM) rating on Tuesday, June 26. Wells Fargo has “Market Perform” rating and $86 target. The stock has “Neutral” rating by Credit Suisse on Thursday, March 2. The firm has “Neutral” rating by UBS given on Wednesday, September 6. The stock has “Hold” rating by Jefferies on Friday, June 23. The firm earned “Hold” rating on Wednesday, August 19 by Citigroup. The stock has “Underperform” rating by Macquarie Research on Wednesday, September 23. The rating was maintained by Jefferies with “Hold” on Monday, February 5.

Investors sentiment decreased to 0.72 in 2018 Q3. Its down 0.21, from 0.93 in 2018Q2. It dived, as 38 investors sold XOM shares while 848 reduced holdings. 112 funds opened positions while 529 raised stakes. 2.17 billion shares or 0.56% more from 2.16 billion shares in 2018Q2 were reported. Stifel Financial reported 3.20 million shares stake. Utah Retirement Systems reported 788,321 shares or 1.3% of all its holdings. Schmidt P J Investment Management Incorporated holds 0.94% in Exxon Mobil Corporation (NYSE:XOM) or 38,939 shares. Lagoda Limited Partnership reported 0.03% in Exxon Mobil Corporation (NYSE:XOM). Beaumont Fincl Prns Limited Liability Company has invested 0.33% of its portfolio in Exxon Mobil Corporation (NYSE:XOM). Phocas Fincl stated it has 0.05% in Exxon Mobil Corporation (NYSE:XOM). Plancorp Limited Liability has invested 1.83% in Exxon Mobil Corporation (NYSE:XOM). Mcdaniel Terry & Co holds 0.68% of its portfolio in Exxon Mobil Corporation (NYSE:XOM) for 47,139 shares. Bp Pcl holds 1.38% or 532,000 shares in its portfolio. Robecosam Ag invested in 0.01% or 2,900 shares. First Business Fincl Service owns 9,126 shares. Cohen Lawrence B accumulated 2.58% or 44,589 shares. Teachers Retirement Sys Of The State Of Kentucky holds 0.42% or 416,484 shares. First Mercantile Com holds 0.19% in Exxon Mobil Corporation (NYSE:XOM) or 11,250 shares. Ing Groep Nv has 0.85% invested in Exxon Mobil Corporation (NYSE:XOM).

Analysts await Exxon Mobil Corporation (NYSE:XOM) to report earnings on February, 1. They expect $1.20 earnings per share, up 36.36% or $0.32 from last year’s $0.88 per share. XOM’s profit will be $5.08 billion for 14.92 P/E if the $1.20 EPS becomes a reality. After $1.46 actual earnings per share reported by Exxon Mobil Corporation for the previous quarter, Wall Street now forecasts -17.81% negative EPS growth.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.